Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

How Long Do You Wait on Nio Stock?

With a cash infusion, electric-vehicle maker Nio won't go down right away. But with competition risks and a pandemic weighing on the company, Nio stock is a very risky investment.

3 Retail Stocks That Are Making the Right Moves

Retail stocks are enjoying a resurgence, as brick-and-mortar companies find distinct ways to compete in the e-commerce environment.

FuelCell Stock Has a Math Problem More Than a Science Problem

FCEL stock is off its recent highs as investors wrestle with the promise of the company's technology versus its lack of sustainable revenue.

Chesapeake Stock Has Problems That Go Beyond a Virus

CHK stock has a crippling debt problem and is now battling falling oil prices that threaten to make servicing that debt more difficult.

How High Can Virus Concerns Take CODX Stock?

Thanks to the need for coronavirus testing, CODX stock has plenty of upside potential – in the near term. Because of its likely ephemeral trajectory, be sure to have your finger on the trigger if you’re going to speculate on it.